Orion Pharma Limited Stock price

Equities

ORIONPHARM

BD0486OPL004

Pharmaceuticals

End-of-day quote Dhaka S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
69.3 BDT +3.59% Intraday chart for Orion Pharma Limited +4.52% -12.94%
Sales 2022 9.66B 88.42M Sales 2023 13.93B 127M Capitalization 18.63B 170M
Net income 2022 846M 7.74M Net income 2023 641M 5.87M EV / Sales 2022 4.04 x
Net Debt 2022 18.45B 169M Net Debt 2023 21.7B 199M EV / Sales 2023 2.9 x
P/E ratio 2022
24.3 x
P/E ratio 2023
29.1 x
Employees 2,716
Yield 2022
1.14%
Yield 2023
1.26%
Free-Float 68.02%
More Fundamentals * Assessed data
Dynamic Chart
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Orion Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Orion Pharma Limited Recommends Cash Dividend for the Year Ended June 30, 2022 CI
Orion Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Orion Pharma Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020 CI
Orion Pharma Limited Recommends Cash Divided for the Year Ended on June 30, 2020 CI
Orion Pharma Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020 CI
Orion Pharma Limited Appoints Zareen Karim as Managing Director CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2019 CI
Orion Pharma Limited Recommends Cash Dividend for the Year Ended on June 30, 2019 CI
More news
1 day-1.91%
1 week+0.90%
Current month-17.31%
1 month-15.42%
3 months-15.95%
6 months-15.95%
Current year-15.95%
More quotes
1 week
66.60
Extreme 66.6
74.00
1 month
64.00
Extreme 64
82.50
Current year
64.00
Extreme 64
91.80
1 year
64.00
Extreme 64
91.80
3 years
42.30
Extreme 42.3
156.50
5 years
25.20
Extreme 25.2
156.50
10 years
25.20
Extreme 25.2
156.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 09-12-31
Director of Finance/CFO - -
Compliance Officer - -
Members of the board TitleAgeSince
Chairman 69 -
Director/Board Member 68 84-12-31
Director/Board Member 42 09-12-31
More insiders
Date Price Change Volume
24-03-27 69.3 +3.59% 719 765
24-03-27 66.9 -1.91% 856,705
24-03-25 68.2 -2.57% 1,252,614
24-03-24 70 -1.96% 1,991,590
24-03-21 71.4 +7.69% 1,879,914

End-of-day quote Dhaka S.E., March 26, 2024

More quotes
Orion Pharma Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health- related consumer products. The Company's products include Ambronil, Angimet MR, Arovent, Axet, Avison, Azalid, Angimet, Alve, Anvert, Baclon, Betacal, Bisoloc, Bonec, Broket, Bromazep, Boncare, Sefin, Stimulin, Silvage, ROVEX, Rupenta, Rispa, Riz, Rivo, Procap, Pep Plus, Pep, Pedicon, Pedicef, Oranex Capsule, Orsal Syrup, Orsal, Ortac, Ormin, Orlev, Orioplex, Oriodox, Orfenac, Onium, Onasia, Oclazid, Novoxen, Novodol Tablet, Nidazyl, Nervex, NOVELTA, Nosedex, Noak, Newage, Neulyn, Nugesic, Losan-D, Losan D, Losan, Lopres, Lipex, GoldKid, Goldage, Glory, Ezylax Syrup, Eroflam, Exor, Eprel, ESP, Enliven, EC PLUS, EC, Deslor Plus, Deslor, Deconil, Cosy, Co-Axet, Cloramin Syrup, Cefditor, Conaz, Combivit, Clognil Plus, Clognil and CCB.
More about the company
  1. Stock
  2. Equities
  3. Stock Orion Pharma Limited - Dhaka S.E.